News Focus
News Focus
Followers 29
Posts 617
Boards Moderated 0
Alias Born 08/25/2023

Re: jobynimble post# 189

Wednesday, 10/23/2024 11:06:52 AM

Wednesday, October 23, 2024 11:06:52 AM

Post# of 300
NASDAQ: $CRDL is advancing CardiolRx for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million, with key trial results due in November 2024?
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDL News